• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Laguna Blends Over Subscribes Private Placement and Closes Second Tranche for 2,305,666 Units for Total Proceeds of $345,850

    Matthew Spizziri
    Feb. 10, 2017 07:36AM PST
    Biotech Investing
    Biotech Investing

    KELOWNA, BC – February 9, 2017 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) is pleased to announce the closing of the second tranche of its non-brokered private placement (the “Private Placement”).

    KELOWNA, BC – February 9, 2017 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) is pleased to announce the closing of the second tranche of its non-brokered private placement (the “Private Placement”). The second tranche consisted of the issuance of 2,305,666 units at a price of $0.15 per unit for gross proceeds of $345,850. The Company over subscribed the private placement for a total of 7,848,995 units for gross proceeds of $1,177,350. Each unit consists of one common share and one share purchase warrant, each warrant entitling the holder to acquire one additional common share of the Company at a price of $0.25 per warrant share for a period of twelve months. The Warrants are subject to an acceleration provision of the Company whereby, in the event that the Company’s common shares trade above $0.30 per share on the Canadian Securities Exchange (CSE) for a period of ten consecutive trading days, the warrants will terminate on the date that is 30 days following receipt of a call notice in the event the holder has not exercised the warrants by such date.
    All securities issued are subject to a hold period expiring four months and one day from the date of issuance. In connection with the private placement, the company paid a cash or shares finder’s fee of up to 7 per cent.
    Read the full company profile.
    About Laguna Blends Inc.
    Laguna Blends is a market leader in the distribution of Hemp and CBD products. Lagunas
    growth strategy includes acquiring and incubating companies who formulate and or
    manufacture Hemp products. Laguna Blends markets Hemp products utilizing its B to B
    Network along with driving traffic to its Club 8 online marketplace. It’s Lagunas intent to
    provide the highest quality hemp product experience for the end user, utilizing a proprietary
    nanotechnology in many of its consumable and topical skin care products. Laguna is currently
    seeking joint ventures and acquisitions to expand its portfolio and will aggressively begin
    international expansion into Asia and Europe in 2017.
    ON BEHALF OF THE BOARD
    “Ray Grimm Jr” CEO, President & Director
    CORPORATE COMMUNICATIONS:
    Howe & Bay Financial: 604-449-5302
    1.604.449.5302
    COMPANY:
    Laguna Blends
    ir@lagunablends.com
    www.lagunablends.com
    cbdskincream.com
    Join Us On Face Book: https://www.facebook.com/LagunaBlends/
    Twitter: @LagunaBlends
    Forward-Looking Information:
    This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
    Connect with Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) to receive an Investor Presentation.

    cbd productsjoint ventureslaguna blendseuropelaguna blends inchemp productshemp and cbd
    The Conversation (0)

    Go Deeper

    AI Powered

    TransCanna Announces Five Year Deal with Fresca LLC

    Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×